Eczema from the Inside Out: A Functional Medicine Approach
Eczema isn't just a skin problem — it starts in the gut and immune system. Learn root causes, trigger identification, and natural approaches backed by research.
Dr. Rebecca J. Adams, DO · Family Medicine · · 10 min read
Reviewed by Dr. Veda Johnson, ND
Key Takeaways
- ✓Eczema (atopic dermatitis) is an immune-mediated condition driven by Th2 immune dominance, not just a skin barrier problem
- ✓Food sensitivities — particularly dairy, eggs, wheat, and soy — trigger or worsen eczema in 30-40% of children and a significant subset of adults
- ✓Gut dysbiosis precedes eczema development: infants with low Bifidobacterium diversity are at higher risk of developing atopic dermatitis
- ✓Probiotics (especially L. rhamnosus GG), vitamin D optimization, and omega-3s have evidence for reducing eczema severity
The conventional approach to eczema follows a predictable pattern: moisturize, apply steroid cream when it flares, try stronger steroids when mild ones stop working, consider immunosuppressants for severe cases. At no point does anyone ask: why is your immune system attacking your skin?
Eczema (atopic dermatitis) affects 10-20% of children and 2-10% of adults worldwide. It's not just a cosmetic nuisance — it disrupts sleep, causes chronic discomfort, affects mental health, and signals underlying immune dysregulation that extends far beyond the skin.
The Immune Story
Eczema is driven by a Th2-dominant immune response. In healthy immune function, Th1 (cellular defense against infections) and Th2 (allergic/parasitic defense) are balanced. In eczema, Th2 is overactive, producing excess IL-4, IL-5, and IL-13 — cytokines that promote allergic inflammation, impair skin barrier function, and increase IgE production (Weidinger & Novak, 2016).
Skin barrier dysfunction (often involving filaggrin gene mutations) allows allergens and irritants to penetrate, triggering immune activation. But the barrier problem and the immune problem are intertwined: Th2 cytokines themselves suppress filaggrin production, worsening the barrier. It's a vicious cycle.
The Gut Connection
The gut-skin axis in eczema is supported by compelling evidence:
Microbiome precedes disease: Prospective studies show that infants who develop eczema have different gut microbiome composition at birth — specifically lower Bifidobacterium diversity — compared to infants who remain eczema-free (Abrahamsson et al., 2012). The gut microbiome shapes immune development in the critical first years of life.
Gut permeability: Children with eczema show increased intestinal permeability on lactulose-mannitol testing. When undigested food proteins cross the compromised gut barrier, they encounter immune cells that mount Th2-skewed responses — manifesting as skin inflammation.
Probiotics prevent eczema: The most replicated finding in probiotic research: L. rhamnosus GG given to mothers during the last month of pregnancy and to infants for 6 months reduced eczema incidence by 50% at age 2 (Kalliomaki et al., 2001). This landmark study has been replicated in multiple populations.
Food Triggers
The role of food in eczema is sometimes dismissed by dermatologists but supported by substantial evidence:
A systematic review found that 33-63% of children with moderate-severe eczema have clinical improvement with elimination of identified food triggers. The most common triggers: cow's milk (most frequent), eggs, wheat, soy, peanuts, tree nuts, and fish (Eigenmann et al., 1998).
In adults, food triggers are less universal but still significant. Common adult triggers include dairy, gluten, eggs, and histamine-rich foods (fermented foods, aged cheese, wine, cured meats). Histamine intolerance — from reduced DAO enzyme activity — can drive eczema flares through mast cell activation.
The gold standard: 3-4 week strict elimination of dairy, gluten, eggs, soy, and corn, followed by systematic reintroduction (one food every 3 days, monitoring for skin reactions within 72 hours).
Nutrient Approaches
Vitamin D: Eczema severity correlates inversely with vitamin D levels. A meta-analysis of 11 RCTs found vitamin D supplementation significantly reduced eczema severity scores, particularly in patients with baseline deficiency (Kim & Bae, 2016). Target: 40-60 ng/mL. Most eczema patients are deficient.
Omega-3 fatty acids: EPA and DHA modulate the Th1/Th2 balance and reduce inflammatory eicosanoid production. Supplementation during pregnancy reduced eczema incidence in offspring. For existing eczema, 2-3g EPA+DHA daily may reduce severity.
Evening primrose oil (EPO) / borage oil: Rich in gamma-linolenic acid (GLA), which supports skin barrier function and anti-inflammatory prostaglandin production. Results in trials are mixed — some show benefit for mild-moderate eczema at doses of 2-4g EPO daily.
Zinc: Zinc deficiency impairs skin barrier repair and immune regulation. Serum zinc is often low in eczema patients. 15-30mg zinc picolinate daily supports skin healing and immune modulation.
Beyond Supplements
Wet wrap therapy: Applying moisturizer, then wrapping affected areas with damp cotton (followed by dry layer) overnight. Reduces itch, improves barrier hydration, and can reduce steroid use by 70%. Well-studied in pediatric eczema.
Stress management: Eczema and psychological stress have a bidirectional relationship — stress triggers flares, and visible eczema causes psychological distress. Mindfulness-based interventions reduced eczema severity in controlled studies.
Environmental controls: Fragrance-free products, gentle laundry detergent, cotton clothing, humidifier use in dry climates, avoiding hot water (use lukewarm), and identifying environmental triggers (dust mites, pet dander, mold).
When to See a Practitioner
If eczema is moderate-severe, recurrent despite topical treatment, or accompanied by other atopic symptoms (asthma, allergies), consider a functional medicine evaluation. Testing should include: food sensitivity assessment (elimination diet preferred over blood panels), vitamin D level, comprehensive stool analysis (gut microbiome composition), IgE panel, and thyroid function. Addressing the gut-immune-skin axis often reduces flare frequency and steroid dependence significantly.